A Study Evaluating the Nutritional Supplement on Skin Parameters in Healthy Female Subjects

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement and its Impact on Skin Parameters in Healthy Female Subjects - A Study Evaluating the Nutritional Supplement on Skin Parameters in Healthy Female Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039177

Enrollment

Registered

2020-01-16

Start date

2020-01-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test food daily intake, for 12 weeks Intake of placebo daily intake, for 12 weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Subjects must have Fitzpatrick skin Type II or III Subjects who have Glogau skin classification type II

Exclusion criteria

Exclusion criteria: Subjects in menopause. Those on current use or use within 1 month of research enrollment of hormonal therapies. Those on current regular use or regular use within 1 month of research enrollment of steroids. Those in chronic or relapsing inflammatory and/or allergic skin conditions. Pregnant lactating or breastfeeding women. Subjects who have a history of skin cancer or currently have skin cancer. Those currently with active herpes infections or currently on treatment for herpes infections. Those with a history of facial keloids. Those with current diagnosis of adult acne or currently on treatment for adult acne. Those with recent cardiovascular conditions. Those on potent blood thinners. Those with a current diagnosis of diabetes mellitus. Those who have received facial irradiation within the last 1 year or are planning on undergoing facial irradiation during the research. Those with chronic liver disease. Those with chronic kidney disease. Those who currently take supplements containing carotenoids. Those with occupations or lifestyle that require(s) significant daily exposure to the sun. Subjects who have had previous facial irradiation. Those who plan to undergo invasive facial procedures. Those who are HIV positive. Those who are immunosuppressed. Those with a recent diagnosis of a psychiatric condition. Those with chronic connective tissue disorder affecting the skin. Those with autoimmune skin diseases. Those who have been prescribed retinoids treatment. Those who have smoking habits. Those who take excessive amounts of alcoholic drinks. Those who use illicit or illegal drugs. Those who are regular users of cannabis substances or substances derived from cannabis. Those who are planning a trip to the mountains or to a higher UV index region. Those who are experiencing perimenopausal or menopausal symptoms. Those who have had a hysterectomy and/or both of their ovaries removed.

Design outcomes

Primary

Measure	Time frame
VISIA	—

Countries

Japan

Contacts

Public ContactElizabeth Tarshish

Lycored Ltd. none

Elizabeth.Tarshish@lycored.com+972732327323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026